Literature DB >> 20128533

Corneal collagen cross-linking with riboflavin and UVA irradiation in pellucid marginal degeneration.

Leopoldo Spadea1.   

Abstract

PURPOSE: To report the results of corneal collagen cross-linking (CXL) with riboflavin and ultraviolet A irradiation in a patient affected by pellucid marginal degeneration (PMD).
METHODS: A 43-year-old man with bilateral PMD underwent CXL in the left eye. The treatment was performed in standard fashion with the exception of slightly inferior decentration of the 9 mm-diameter irradiated area preserving an untreated surface area 1 mm from the limbus.
RESULTS: Epithelial regrowth was complete after 4 days' use of a bandage soft contact lens. No side effects or damage to the limbal region were observed during re-epithelialization or during follow-up. Corrected distance visual acuity improved from 20/200 to 20/63 at 3 months and was stable through the 12-month interval. Keratometric astigmatism showed a 1.40-diopter (D) reduction and the power of ectasia apex decreased from 82.00 D to 78.00 D.
CONCLUSIONS: Corneal collagen CXL was a safe tool in the management of PMD, improving some parameters in advanced stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128533     DOI: 10.3928/1081597X-20100114-03

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  26 in total

1.  Mini-incision cataract surgery and toric lens implantation for the reduction of high myopic astigmatism in patients with pellucid marginal degeneration.

Authors:  A Balestrazzi; S Baiocchi; A Balestrazzi; G Cartocci; G M Tosi; G Martone; P Michieletto
Journal:  Eye (Lond)       Date:  2015-02-27       Impact factor: 3.775

Review 2.  Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies.

Authors:  Maria Gkika; Georgios Labiris; Vassilios Kozobolis
Journal:  Int Ophthalmol       Date:  2011-08-17       Impact factor: 2.031

Review 3.  Corneal collagen cross-linking: a review.

Authors:  David P S O'Brart
Journal:  J Optom       Date:  2014-03-20

4.  Evaluation of the in vitro antimicrobial properties of ultraviolet A/riboflavin mediated crosslinking on Candida albicans and Fusarium solani.

Authors:  Bing Sun; Zhi-Wei Li; Hai-Qun Yu; Xiang-Chen Tao; Yong Zhang; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

5.  Visual rehabilitation in low-moderate keratoconus: intracorneal ring segment implantation followed by same-day topography-guided photorefractive keratectomy and collagen cross linking.

Authors:  Ferial M Zeraid; Asma A Jawkhab; Waleed S Al-Tuwairqi; Uchechukwu L Osuagwu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

6.  In vivo confocal laser microscopy of morphologic changes after small incision lenticule extraction with accelerated cross-linking (SMILE Xtra) in patients with thin corneas and high myopia.

Authors:  Yugui Zhou; Manli Liu; Ting Zhang; Hua Zheng; Yuan Sun; Xiaonan Yang; Shengbei Weng; Haiqin Lin; Quan Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-29       Impact factor: 3.117

7.  Evaluation of the efficacy of excimer laser ablation of cross-linked porcine cornea.

Authors:  Shihao Chen; Yini Li; Aleksander Stojanovic; Jia Zhang; Yibo Wang; Qinmei Wang; Theo Seiler
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

8.  Collagen cross-linking: current status and future directions.

Authors:  Marine Hovakimyan; Rudolf F Guthoff; Oliver Stachs
Journal:  J Ophthalmol       Date:  2012-01-12       Impact factor: 1.909

9.  Lens Densitometry after Corneal Cross-linking in Patients with Keratoconus Using a Scheimpflug Camera.

Authors:  Alireza Baradaran-Rafii; Mohammad Aghazazeh Amiri; Sahar Mohaghegh; Mehran Zarei-Ghanavati
Journal:  J Ophthalmic Vis Res       Date:  2015 Apr-Jun

10.  Transepithelial corneal collagen cross-linking in ultrathin keratoconic corneas.

Authors:  Leopoldo Spadea; Rita Mencucci
Journal:  Clin Ophthalmol       Date:  2012-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.